Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Starbucks Corp (SBUX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Starbucks Corp — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Starbucks Corp trades at $92.95 (market cap $106.68B). The key difference: Starbucks Corp is far larger — about 22.6× Definium Therapeutics Inc. Common Shares's market cap, and Starbucks Corp pays a 2.65% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Starbucks Corp for 190 Days on average.
| DFTX | SBUX | |
|---|---|---|
Market Cap | $4.71B | $106.68B |
Volume | 1,966,636 | 9,406,993 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $108.55 |
52-Week Low | $10.68 | $78.46 |
Typical Hold Time | 0 Days | 190 Days |
Enterprise Value | $3.67B | $125.51B |
Dividend Yield | — | 2.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Starbucks (SBUX) trades at $93.21, down 3.02% amid a bearish technical signal and store closure announcements. The company shows mixed fundamentals with a high P/E ratio of 54.09 but strong recent earnings beats. Revenue grew to $37.18B in 2025, though net income declined to $1.86B. Analyst consensus remains positive with a $115.50 price target, while technical indicators show support at $91-$93 levels.
The outlook balances restructuring benefits against execution risks. Store closures may improve efficiency but pose near-term headwinds. With solid cash flow and analyst support, SBUX offers recovery potential, though high valuation and labor relations require monitoring for sustained shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Starbucks Corp
Starbucks Corporation retails, roasts, and provides its own brand of specialty coffee. The Company operates retail locations worldwide and sells whole bean coffees through its sales group, direct response business, supermarkets, and on the world wide web. Starbucks also produces and sells bottled coffee drinks and a line of ice creams.
Read more on SBUX →
